Quantcast
Connect with us

Mylan pushed for law to make EpiPens mandatory in US schools — then fled overseas to avoid taxes

Published

on

EpiPens are mandatory for public schools in at least 11 states after Congress passed a law recommending their use — but the drug’s manufacturer pays no U.S. taxes at all after relocating overseas.

Mylan spent $4 million lobbying Congress to pass the 2013 School Access to Emergency Epinephrine Act, which offers incentives to schools to stock the potentially life-saving auto-injectors.

About a year and a half later, Mylan completed a corporate inversion to change its legal residence to the Netherlands, a tax haven, while keeping its headquarters and most of its employees in the Pittsburgh area.

The move allowed Mylan to cut its U.S. effective tax rate from 9.4 percent in 2013, the year Congress helped protect its market dominance, to negative 4.7 percent in 2015, according the group Americans For Tax Fairness.

Mylan’s worldwide effective tax rate fell after moving to the Netherlands from 16.2 percent to 7.4 percent — even as its global profits shot up by 22.5 percent between 2013 and 2015.

The company receives millions in U.S. taxpayer funding through federal programs such as Medicaid and the Children’s Health Insurance Program, which has helped offset consumer costs as Mylan has jacked up EpiPen prices.

ADVERTISEMENT

EpiPens now cost $609, more than twice the $265 rate in 2013 and more than five times higher than their $104 cost in 2009, not long after the company acquired the drug from the German drugmaker Merck.

The company’s CEO, Heather Bresch, has raised her own pay at similar rates to the drug she lobbied Congress to promote through federal law.

Bresch took home $4.9 million in 2009, but last year she made $13.1 million — and the year before, when she moved Mylan overseas after securing the Emergency Epinephrine Act, she made a whopping $25.8 million.

The CEO’s father, U.S. Sen. Joe Manchin (D-WV), was not among the 27 Democratic sponsors of the bill — which also drew 10 Republican co-sponsors and one independent.

ADVERTISEMENT

The pharmaceutical company’s “EpiPen4Schools” program, which started in August 2012, before the bill was passed but after it was introduced, offers free or discounted EpiPens to schools with one catch.

To qualify for the discounted $112.10 price, schools must agree not to purchase similar products — such as the lesser known Adrenaclick — from Mylan’s competitors.

A spokesperson for the company said the competition requirement was no longer part of the program and did not say when it was ended, but it was apparently still shown on order forms as recently as June 2015, STAT reported.

Mylan also helps keep the drug’s price artificially high by funding Snack Safely, the public relations arm of the nonprofit Food Allergy Research and Education group.

ADVERTISEMENT

Snack Safely publishes social media-ready blog posts promoting Mylan’s interests — such as arguing against a petition drive to make EpiPens available over-the-counter, which would dramatically cut its cost.

Watch Bresch discuss Mylan’s corporate inversion in this 2015 interview with Fortune:

READ MORE:

 

Report typos and corrections to [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Israel’s Netanyahu just christened a building named after Trump — that doesn’t even exist

Published

on

Israeli Prime Minister Benjamin Netanyahu spent his Father’s Day dedicating a new Trump Tower-type building that hasn't been built in a town that doesn't exist.

Standing in front of a large sign saying "Trump Heights," Netanyahu, who is being forced back into another election, announced the building before planning even began, Axios reported.

A great day on the Golan. PM Netanyahu and I had the honor to dedicate “Trump Heights” — first time Israel has dedicated a village in honor of a sitting president since Harry Truman (1949). Happy Birthday Mr. President!! @POTUS pic.twitter.com/fdYWzokFLK

Continue Reading

Breaking Banner

This graphic explains why Speaker Pelosi is resistant to impeachment

Published

on

House Speaker Nancy Pelosi (D-CA) has told her caucus that they can do investigations into the president without impeachment. The difference, however, is that there are fewer legal benefits available to Congress in their oversight role than in impeachment.

Theoretically, it should enable Democrats to do the research they need, but the White House is taking the bold step to defy the oversight the Constitution outlines. The only option open to the Democrats has been to go to court with their case outlining how the White House is breaking the law. Thus far, they've won two lawsuits about their investigations, and they will likely gain more.

Continue Reading
 

Breaking Banner

Trump says if GOP paid for Steele dossier ‘there’d be hell to pay’ — Republicans paid for half of it

Published

on

President Donald Trump tweeted out once again that he doesn't know the difference between a man hired to do opposition research and an entire country intruding on an election to sway the result.

In a Sunday Twitter rant, Trump proclaimed that if Republicans had done something like that, "there'd be hell to pay."

......If Republicans ever did that to the Democrats, there would be all hell to pay. It would be a scandal like no other!

— Donald J. Trump (@realDonaldTrump) June 16, 2019

Continue Reading
 
 

Copyright © 2019 Raw Story Media, Inc. PO Box 21050, Washington, D.C. 20009 | Masthead | Privacy Policy | For corrections or concerns, please email [email protected]

I need your help.

Investigating Trump's henchmen is a full time job, and I'm trying to bring in new team members to do more exclusive reports. We have more stories coming you'll love. Join me and help restore the power of hard-hitting progressive journalism.

TAKE A LOOK
close-link

Investigating Trump is a full-time job, and I want to add new team members to do more exclusive reports. We have stories coming you'll love. Join me and go ad-free, while restoring the power of hard-hitting progressive journalism.

TAKE A LOOK
close-link